SOUTHWEST NODE
SOUTHWEST NODE (no longer active)

Michael Bogenschutz, MD [email]
Principal Investigator

University of New Mexico
Center on Alcoholism, Substance Abuse & Addictions (CASAA)
2650 Yale Southeast
Albuquerque, NM 87106

Find Node Publications
Node Facebook page
Node web site
NIDA web site

The Southwest Node joined the Clinical Trials Network in September 2002 and includes programs in New Mexico. The node's community treatment programs provide inpatient and outpatient, urban and rural psychotherapy and pharmacotherapy. New Mexico is the first "minority majority" state, and its clinical populations include large proportions of Native American and Hispanic clients.

This node is no longer active in the CTN.


SOUTHWEST NODE PROTOCOL INVOLVEMENT

CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation
CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescent/Young Adults
CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
CTN-0013 Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users
CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
CTN-0020 Job Seekers Training for Patients with Drug Dependence
CTN-0020-A-1 Job Seekers' Training for Clients/Relatives with Drug Dependence (Specific to the Na'Nizhoozhi Center, Inc.)
CTN-0021 Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse
CTN-0032 HIV Rapid Testing and Counseling
CTN-0032-A-1 Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs
CTN-0033-Ot-2 Methamphetamine Use and Treatment in Native American Communities in the Southwest
CTN-0041-S Relationships Between Demographic Characteristics of Patients and Therapists, Measures of Therapeutic Process and Therapeutic Alliance, and Outcomes
CTN-0047 Screening Motivational Assessment and Referral to Treatment in Emergency Departments (SMART-ED): Evaluation of Screening, Brief Intervention, Referral to Treatment (SBIRT) and Booster Session for Drug Use Patients Presenting for Treatment in the Emergency Department
CTN-0051

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)

CTN-0051-A-1

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Genetics Study

 

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 5/2014 -- http://ctndisseminationlibrary.org/nodes/swnode.htm
info@ctndisseminationlibrary.org